Also, we failed to capture some of the genomic alterations that were commonly involved in CH (the cfDNA panels did not include ASXL1, DNMT3A, PPM1D, TET2, etc.)(Table S1). This evidence concerns the gene ASXL1 and cyclic hematopoiesis.